Trends in amyloid burden differed significantly across paths ( P < .001): amyloid burden was relatively stable in path B (median slope of −0.0037 SUVR per disease stage, P = .0486) compared to path A, which showed an increasing trend in amyloid (median slope of 0.0522 SUVR per disease stage).
← all excerpts
Characterizing heterogeneity in the progression of Alzheimer's disease using longitudinal clinical and neuroimaging biomarkers.
1
—
—